Early studies indicated that the majority of melanoma tumours retain no expression of E-cadherin as a result of autocrine HGF secretion from melanoma cells activating c-Met and the MAPK and PI3K pathways resulting in E-cadherin downregulation (Li et al., 2001b). The gene discussed is MET; the disease is neoplasm.